Author:
Martín Mola Emilio,Balsa Alejandro,Martínez Taboada Víctor,Sanmartí Raimon,Marenco José Luis,Navarro Sarabia Federico,Gómez-Reino Juan,Álvaro-Gracia José María,Román Ivorra José Andrés,Lojo Leticia,Plasencia Chamaida,Carmona Loreto
Reference91 articles.
1. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview;Singh;CMAJ,2009
2. Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs;Bergman;Semin Arthritis Rheum,2010
3. Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach;Devine;Pharmacotherapy,2011
4. Adverse effects of biologics: a network meta-analysis and Cochrane overview;Singh;Cochrane Database Syst Rev,2011
5. Bristol-Myers Squibb Pharma. ORENCIA 250mg polvo para concentrado para solución para perfusión. Ficha técnica o resumen de las características del producto; 2007 [consultado 15 May 2012]. Disponible en: http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000701/WC500048935.pdf
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献